Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in Man
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemic subjects were fed diets in which dietary fat calories were held constant, but carbohydrate calories were varied. Three subjects with fasting chylomicronemia (Type V) were given less carbohydrate and four subjects without fasting chylomicronemia (Type IV) were fed diets with more calories as carbohydrate. The restricted carbohydrate intake led to disappearance of chylomicronemia in those subjects who had chylomicronemia on a normal diet (Type V to IV). In those subjects without chylomicronemia, chylomicronemia appeared in response to increased carbohydrate intake (Type IV to V). Thus chylomicron concentrations in plasma were altered even though fat intake and presumably chylomicron input into plasma was kept constant. These findings provide evidence for saturation of chylomicron removal mechanisms by alteration of endogenous triglyceride-rich lipoprotein concentrations. They suggest that chylomicrons compete with very low density lipoproteins for similar removal mechanisms. The relationship between endogenous triglyceride concentration and the lipolytic activity in plasma following heparin was then evaluated with the use of long-term heparin infusions to release and maintain lipolytic activity in the circulation. 10 subjects were placed on fatfree diets to remove circulating dietary fat. The plasma lipolytic rate during the heparin infusion was measured consecutively on different days in individuals whose triglyceride concentrations were varied by either increasing or decreasing calories. The lipolytic rate was curvilinearly related to the plasma triglyceride concentrations. This curvilinear relationship followed Michaelis-Menton saturation kinetics over a wide range of triglyceride concentrations on fat-free, high-carbohydrate diets, in multiple studies in a group of individuals. These studies suggest that endogenous and exogenous triglyceride compete for a common, saturable, plasma triglyceride removal system related to lipoprotein lipase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with severe or very severe triglyceride levels (Ն1000 mg/dl), the LpL removal system is saturated (74).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Factors that reduce VLDL clearance can raise triglyceride concentrations in those with high baseline levels (eg, usually Ͼ500 mg/dL, because of the competition of VLDL and chylomicrons for a common saturable removal mechanism).97”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [97]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, chylomicrons compete with endogenous VLDL for the action of LPL [20].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Electrophoretic separation of plasma lipoproteins in agarose gel
Noble, R. P. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42680-x · Cited by 1,307
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
Editorial: A System for Phenotyping Hyperlipoproteinemia
FREDRICKSON, D. S., & LEES, R. S. (1965) · Circulation · doi:10.1161/01.cir.31.3.321 · Cited by 507
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Lipolytic activity of post-heparin plasma in hyperglyceridemia
Fredrickson, D. S., Ono, K., & Davis, L. L. (1963) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40361-x · Cited by 370
Havel, R. J., Kane, J. P., Balasse, E. O., Segel, N., & Basso, L. V. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106422 · Cited by 336
The Metabolic Basis of Inherited Disease
Martin, D. B. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.1967.00300020128027 · Cited by 320
Classification of Hyperlipidemias and Hyperlipoproteinemias
(1972) · Circulation · doi:10.1161/01.cir.45.2.501 · Cited by 257
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma
Reaven, G. M., Hill, D. B., Gross, R. C., & Farquhar, J. W. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105290 · Cited by 221
Research works printed but not linked: 2
- [10]10. Boberg, J. 1971. Mechanisms of hypertriglyceridemia in man. Thesis. Acta Universitatis Upsaliensis, Uppsala, Sweden.
- [19]19. Snedecor, G. W., and W. G. Cochran. 1967. Statistical Methods. The Iowa State University Press, Ames. 6th edition. 456.
Cited by
Items 301–400 of 483
van Barlingen, H. H. J. J., Kock, L. A. W., de Man, F. H. A. F., Erkelens, D. W., & de Bruin, T. W. A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05703-x · Cited by 22
van Beek, A. P., van Barlingen, H. H. J. J., de Ruijter-Heijstek, F. C., Jansen, H., Erkelens, D. W., Dallinga‐Thie, G. M., & de Bruin, T. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33894-3 · Cited by 24
Dunn, F. L., Grundy, S. M., Bilheimer, D. W., Havel, R. J., & Raskin, P. (1985) · Metabolism · doi:10.1016/0026-0495(85)90220-3 · Cited by 23
Jácome-Sosa, M., Hu, Q., Manrique‐Acevedo, C., Phair, R. D., & Parks, E. J. (2021) · JCI Insight · doi:10.1172/jci.insight.148378 · Cited by 26
“Thus, the potential benefits of intestinal lipid storage include slowing evening chylomicron production to reduce plasma competition of TRL particles for lipoprotein lipase-mediated clearance (49).”
Hashimoto, S., Ootani, K., Hayashi, S., & Naito, M. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8482 · Cited by 23
Cabezas, M. C., Verseijden, C., Meijssen, S., Jansen, H., & Erkelens, D. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031329 · Cited by 22
“One of the contributing factors is competition of chylomicrons and very low density lipoproteins (VLDL) for the same clearance mechanism (7, 8).”
BackgroundThe effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study*
Shen, J., Arnett, D. K., Pérez‐Martínez, P., Parnell, L. D., Lai, C., Peacock, J. M., Hixson, J. E., Tsai, M. Y., Straka, R. J., Hopkins, P. N., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.p700033-jlr200 · Cited by 22
Hopkins, P. N., & Williams, R. R. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.11.2560 · Cited by 22
Adamska-Patruno, E., Ostrowska, L., Gościk, J., Waszczeniuk, M., Kretowski, A. J., & Górska, M. (2015) · BioMed Research International · doi:10.1155/2015/147196 · Cited by 23
Medical management of hypertriglyceridemia in pancreatitis
Gligorijevic, N., Stefanović-Račić, M., & Kershaw, E. E. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000956 · Cited by 25
“Once LPL becomes saturated, typically at serum triglyceride levels exceeding 500–700mg/dl [18], clearance of additional chylomicrons and VLDL is impeded, and they begin to accumulate rapidly.”
BackgroundBurggraaf, B., Pouw, N. M. C., Fernández‐Arroyo, S., der Zee, L. C. V. V., van de Geijn, G. M., Birnie, E., Huisbrink, J., van der Zwan, E. M., Mulder, M. T., Rensen, P. C. N., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13960 · Cited by 22
“Chylomicrons normally compete with VLDL for the same lipolytic pathways, leading to accumulation of endogenous VLDL in the postprandial state.(36,37) An increased TRL clearance should therefore result in increased LPL-mediated lipolysis because of lower competition.”
BackgroundThe catabolism of human and rat very low density lipoproteins by perfused rat hearts
Dory, L., Pocock, D., & Rubinstein, D. (1978) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(78)90191-1 · Cited by 20
Pamir, N., McMillen, T. S., Li, Y., Lai, C.-M., Wong, H., & LeBoeuf, R. C. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.018 · Cited by 20
Alves, J. F. R., Britto, R. P. D. A., Ferreira, H. S., Sawaya, A. L., & Florêncio, T. M. D. M. T. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2013.12.007 · Cited by 19
“In turn, the hypertriglyceridemia observed among children with moderate stunting at the beginning of this study can be understood by the fact that malnourished children have decreased body mass, which leads to a reduction in the amount of LPL, favoring a lower clearance of circulating TG.(28) With treatment, there was…”
BackgroundImpaired postprandial lipemic response in chronic kidney disease
Saland, J. M., Satlin, L. M., Zalsos-Johnson, J., Cremers, S., & Ginsberg, H. N. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.031 · Cited by 19
“TG are cleared following a meal parallel the clearance of VLDL TG.(8) Whereas the in vivo clearance of CM TG cannot be assessed independently from that of VLDLTG, the relative importance of hepatic synthesis is smaller in the postprandial state compared with fasting.”
InfluentialChylomicron metabolism by the isolated perfused mouse heart
Mardy, K., Belke, D. D., & Severson, D. L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e357 · Cited by 19
“Chylomicrons are the preferred lipoprotein substrate for LPL (8, 13, 15, 21).”
BackgroundDallongeville, J., Gruson, E., Dallinga‐Thie, G. M., Pigeyre, M., Gomila, S., & Romon, M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602603 · Cited by 23
“particles of hepatic origin that compete with chylomicrons for lipolysis (Brunzell et al., 1973), resulting in improved”
BackgroundExercise and postprandial lipid metabolism – an analysis of the current evidence
Gill, J. M. R. (2004) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200300906 · Cited by 27
Westphal, S. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.030 · Cited by 20
“Consequently, incoming exogenous lipoproteins find less competition with pre-existing VLDL for the common pathway via lipolytic degradation [25].”
BackgroundChan, M. K., Varghese, Z., Persaud, J. W., Baillod, R. A., & Moorhead, J. F. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90297-1 · Cited by 19
Wissler, R. W., & McGill, H. C. (1983) · Preventive Medicine · doi:10.1016/0091-7435(83)90269-4 · Cited by 20
Zotou, E., Magkos, F., Koutsari, C., Fragopoulou, E., Nomikos, T., Sidossis, L. S., & Antonopoulou, S. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1561-0 · Cited by 19
“…Malkova et al. 2000)––but also by reducing the competition between endogenous (VLDL) and exogenous (chylomicrons) lipoproteins for lipoprotein lipase-mediated hydrolysis (Bjorkegren et al. 1996; Brunzell et al. 1973; Fisher et al. 1995), thereby facilitating the clearance of postprandial TRL-TG.”
BackgroundMaraki, M. I., Christodoulou, N., Aggelopoulou, N., Magkos, F., Skenderi, K., Panagiotakos, D. B., Kavouras, S. A., & Sidossis, L. S. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508012233 · Cited by 26
Takanashi, M., Kimura, T., Li, C., Tanaka, M., Matsuhashi, A., Yoshida, H., Noda, A., Xu, P., Takase, S., Okazaki, S., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311931 · Cited by 19
Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment
Chait, A., & Subramanian, S. (2000) · Europe PMC (PubMed Central) · Cited by 36
Effects of exercise on postprandial lipoprotein metabolism
Malkova, D., & Gill, J. M. R. (2006) · Future Lipidology · doi:10.2217/17460875.1.6.743 · Cited by 24
Postprandial lipaemia in menopausal women with metabolic syndrome
Kolovou, G. D., Anagnostopoulou, K. K., Pavlidis, A. N., Salpea, K. D., Hoursalas, I. S., Manolis, A. J., & Cokkinos, D. V. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.01.002 · Cited by 23
Evans, K., Burdge, G. C., Wootton, S. A., Collins, J. M., Clark, M. L., Tan, G. D., Karpe, F., & Frayn, K. N. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.009 · Cited by 20
van Wijk, J. P. H. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.006 · Cited by 18
ROLE OF THE ENTEROHEPATIC CIRCULATION OF BILE SALTS IN LIPOPROTEIN METABOLISM
Cooper, A. D. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70051-0 · Cited by 18
Childs, M. T., Tollefson, J. H., Knopp, R. H., & Bowden, D. A. (1981) · Metabolism · doi:10.1016/0026-0495(81)90214-6 · Cited by 18
Reardon, M., & Steiner, G. A. (1982) · Elsevier eBooks · doi:10.1016/b978-0-12-092480-6.50012-7 · Cited by 18
Multifactorial chylomicronemia syndrome
Chait, A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000846 · Cited by 18
Ünal, R., Pokrovskaya, I. D., Tripathi, P., Monia, B. P., Kern, P. A., & Ranganathan, G. (2008) · Biochemical Journal · doi:10.1042/bj20071559 · Cited by 17
“LPL (lipoprotein lipase) plays a central role in lipid metabolism by regulating the hydrolysis of triacylglycerol (triglyceride)-rich lipoproteins in plasma (chylomicrons and very low density lipoproteins), and generates fatty acids for storage or energy utilization [1].”
Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes
Tomlinson, B., Chan, P., & Lam, C. W. K. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1750949 · Cited by 22
“containing particles are cleared from the circulation by common, saturable pathways and consequently compete for clearance [36].”
BackgroundGroener, J. E. M., Scheek, L. M., van Ramshorst, E., Krauss, X. H., & van Tol, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00287-6 · Cited by 17
Serum Lipid Physiology and the Influence of Glaucoma Medications
Stewart, W. C., & Osterman, J. (1998) · Survey of Ophthalmology · doi:10.1016/s0039-6257(98)00030-7 · Cited by 20
Kinetics of triglyceride rich lipoproteins: chylomicrons and very low density lipoproteins
Barrett, P. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00215-9 · Cited by 20
Schreuder, P. C. N. J., Twickler, T. B., Wang, T., Nakajima, K., Erkelens, D. W., & Dallinga‐Thie, G. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00666-3 · Cited by 16
Acute dietary effects on plasma lipids, lipoproteins and lipolytic enzymes in healthy normal males
Schlierf, G., JESSEL, S., OHM, J., Heuck, C. C., Klose, G., Oster, P., Schellenberg, B., & Weizel, A. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00891.x · Cited by 16
Effects of ethanol intake on lipoprotein lipase activity in adipose tissue of fasting subjects
Nilsson‐Ehle, P., Carlström, S., & Belfrage, P. (1978) · Lipids · doi:10.1007/bf02533714 · Cited by 16
Miller, N. E., & Nestel, P. J. (1975) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1975.tb00451.x · Cited by 16
Sibiya, S., Msibi, B., Khathi, A., Sibiya, N. H., Booysen, I. N., & Ngubane, P. S. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0369 · Cited by 15
“The insulin-induced hepatomegaly is association with inflammation as a result of fatty deposition, which may progress to scarring of the liver tissue to cirrhosis (Brunzell et al. 1973).”
BackgroundTriglyceride Treatment in the Age of Cholesterol Reduction
Agrawal, N., Corradi, P. F., Gumaste, N., & Goldberg, I. J. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.08.003 · Cited by 15
Severe hypertriglyceridemia with a history of treatment failure
Capell, W. H., & Eckel, R. H. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0025 · Cited by 15
“The LPL-clearance system becomes saturated with increasing triglyceride burden”
BackgroundIntravenous Fat Tolerance Test with Intralipid® in Chronic Renal Failure
Norbeck, H., & Rössne, S. (1982) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1982.tb01905.x · Cited by 15
Zsigmond, E. M., Fuke, Y., Li, L., Kobayashi, K., & Chan, L. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32173-8 · Cited by 15
Role of Fluid Milk in Attenuating Postprandial Hyperglycemia and Hypertriglyceridemia
Leary, M. P., & Tanaka, H. (2020) · Nutrients · doi:10.3390/nu12123806 · Cited by 15
“In a postprandial state, LPL availability becomes limited due to competition for binding sites and causes triglyceride-rich lipoproteins such as chylomicrons to accumulate [9,51].”
BackgroundPatsch, W., Patsch, J. R., & Gotto, A. M. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30643-5 · Cited by 23
Postprandial dyslipidaemia in a nutshell: food for thought
Watts, G. F., Mamo, J. C. L., & Redgrave, T. G. (1998) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1998.tb01560.x · Cited by 16
Alterations in the Metabolism of Exogenous Lipid Associated with Sepsis
Dahn, M. S., Kirkpatrick, J. R., & Blasier, R. B. (1984) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607184008002169 · Cited by 14
The Common Hyperlipoproteinemias: An Understanding of Disease Mechanisms and Their Control
Fisher, W. R., & TRUITT, D. H. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-497 · Cited by 16
Toor, A., Toor, A., Khalighi, K., & Krishnamurthy, M. (2019) · Case Reports in Endocrinology · doi:10.1155/2019/6273196 · Cited by 14
“This is to decrease the risk of postprandial chylomicronemia since lipoprotein lipase (LPL) levels are maximally saturated from existing severe elevations of TG levels [9].”
Robins, S. J., Fasulo, J. M., Robins, V. F., & Patton, G. M. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.6.e860 · Cited by 13
Hwu, C., Kwok, C., Kuo, C., Hsiao, L., Lee, Y. S., Wei, M.-C., Kao, W., Lee, S. H., & Ho, L. ‐. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001426 · Cited by 14
The biochemical composition and metabolism of lipoproteins in type V hyperlipoproteinaemia
Simons, L. A., & Williams, P. F. (1975) · Clinica Chimica Acta · doi:10.1016/0009-8981(75)90424-6 · Cited by 13
Hayashi, T., Ai, M., Goto, S., Nakamura, M., Nagaike, H., Suzuki, R., Abe, Y., Ohta, M., Ito, Y., & Hirano, T. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63383 · Cited by 12
Sun, C., McCudden, C. R., Brisson, D., Shaw, J. L. V., Gaudet, D., & Ooi, T. C. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz010 · Cited by 15
Approach to the Patient With Moderate Hypertriglyceridemia
Subramanian, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac085 · Cited by 13
Diabetic hypertriglyceridemia-induced acute pancreatitis masquerading as biliary pancreatitis
Huang, D. B., & Raskin, P. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00183-0 · Cited by 12
Dallongeville, J., Harbis, A., Lebel, P., Defoort, C., Lairon, D., Fruchart, J., & Romon, M. (2002) · Journal of Nutrition · doi:10.1093/jn/132.8.2161 · Cited by 16
“Because chylomicrons and VLDL share the same catabolic pathway (33), this compensation very likely applies to postprandial TRL triglyceride metabolism.”
BackgroundSaito, H., Kato, M., Yoshida, A., & Naito, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.erratum22681 · Cited by 11
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
Adiels, M., Mardinoğlu, A., Taskinen, M., & Borén, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00342 · Cited by 15
“Therefore, such models must include that apoB48- and apoB100-containing particles are cleared from the circulation by common pathways and therefore compete for clearance (Brunzell et al., 1973).”
BackgroundInvited Review: Lipoprotein Lipase and Triglyceride‐Rich Lipoprotein Metabolism
Miles, J. M., Park, Y., & Harris, W. S. (2001) · Nutrition in Clinical Practice · doi:10.1177/088453360101600502 · Cited by 14
Glascock, R. F., Smith, R. W., & Walsh, A. (1983) · The Journal of Agricultural Science · doi:10.1017/s0021859600036339 · Cited by 11
Apolipoproteins in lipid transport, an impressionist view
Erkelens, D. W. (1989) · Postgraduate Medical Journal · doi:10.1136/pgmj.65.763.275 · Cited by 12
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia)
Haffner, S. M., Kushwaha, R. S., & Hazzard, W. R. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00264.x · Cited by 11
Self-citationYildirim, V., ter Horst, K. W., Gilijamse, P. W., van Harskamp, D., Schierbeek, H., Jansen, H., Schimmel, A. W. M., Nieuwdorp, M., Groen, A. K., Serlie, M. J. M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166905 · Cited by 10
“In line with earlier reports, we hypothesize that this is primarily due to the competition for LPL-mediated lipoprotein lipolysis (46–50).”
Hazzard, W. R., Kushwaha, R. S., Applebaum-Bowden, D. M., Haffner, S. M., Steinmetz, A., & Foster, D. M. (1984) · Metabolism · doi:10.1016/0026-0495(84)90239-7 · Cited by 10
Self-citationSnehalatha, C., Sivasankari, S., Satyavani, K., Viswanathan, V., & Ramachandran, A. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00136-9 · Cited by 10
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy
Steinberg, F. M., Tsai, E. C., Brunzell, J. D., & Chait, A. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42008-5 · Cited by 10
Self-citationBjörkegren, J., Karpe, F., Vitols, S., Tornvall, P., & Hamsten, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33903-1 · Cited by 10
Insulin Resistance and Dyslipidemia: Implications for Coronary Heart Disease Risk
Laws, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_14 · Cited by 11
4 Alcohol and abnormalities of lipid metabolism
Janus, E. D., & Lewis, B. (1978) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(78)80021-8 · Cited by 10
Hirano, T., Mamo, J. C. L., & Takahashi, T. (1990) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.36.4-supplementi_399 · Cited by 10
Approach to the Adult Patient with Chylomicronemia
Hegele, R. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf701 · Cited by 14
Wilke, R. A. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.86 · Cited by 9
Zhang, F., Lim, W. L. F., Huang, Y., Lam, S. M., & Wang, Y. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100605 · Cited by 9
“Accordingly, the lower ambient triglyceride levels in the circulation of responders at baseline would expectably present less competition for LPL action, as endogenous and exogenous neutral lipids both compete for a common, saturable removal system capped by LPL activity (64).”
Ibrahim, M. A., Bonfiglio, S. M., Schlögl, M., Vinales, K. L., Piaggi, P., Venti, C. A., Walter, M. F., Krakoff, J. A., & Thearle, M. S. (2017) · Obesity · doi:10.1002/oby.22068 · Cited by 10
“We hypothesize this may indicate that metabolism of the carbohydrates consumed the day before was still ongoing or that the activity of lipoprotein lipase, a key enzyme involved in the removal of triglycerides from plasma (30), was inhibited to a greater degree with the WW diet.”
BackgroundMuller, D. P. R., Pavlou, C., Whitelaw, A. G., & McLintock, D. G. (1978) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1978.tb10466.x · Cited by 10
BURNETT, J., Telford, D. E., Barrett, P. H. R., & Huff, M. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.11.010 · Cited by 10
Postprandial lipemia and obesity—any unique features?
Berglund, L. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.299 · Cited by 9
Approach to patients with hypertriglyceridemia
Chait, A., & Feingold, K. R. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101659 · Cited by 11
Fernández, J. M., Silva‐Grigoletto, M. E. D., Ruano, J., Caballero‐Villarraso, J., Moreno‐Luna, R., Túnez‐Fiñana, I., Tasset-Cuevas, I., Pérez‐Martínez, P., López‐Miranda, J., & Pérez‐Jiménez, F. (2008) · Clinical Science · doi:10.1042/cs20080120 · Cited by 9
Sun, C., Brisson, D., Gaudet, D., & Ooi, T. C. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.09.006 · Cited by 9
Quilomicronemia familiar y quilomicronemia multifactorial
Muñiz-Grijalvo, O., & Díaz-Díaz, J. L. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.02.011 · Cited by 9
Elam, M. B., von Wronski, M. A., Cagen, L. M., Thorngate, F. E., Kumar, P., Heimberg, M., & Wilcox, H. G. (1999) · Lipids · doi:10.1007/s11745-999-0427-z · Cited by 8
“Although, to our knowledge, VLDL clearance has not been specifically studied in the fatty Zucker rat, chylomicron remnants and VLDL share a common removal mechanism ( 34 ).”
BackgroundTherapeutic considerations for postprandial dyslipidaemia
Burnett, J. R., & Watts, G. F. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00155.x · Cited by 8
Type V Hyperlipoproteinaemia Re‐visited: Findings in a Sydney Population*
Simons, L. A., Williams, P. F., & Turtle, J. R. (1975) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1975.tb04570.x · Cited by 8
Edelstein, C., Fredenrich, C., Schuelke, J., Jensen, W. E., Sitrin, M. D., Iverius, P., & Scanu, A. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90043-n · Cited by 8
Disposition of lipids in the postprandial state
Williams, C. M. (1996) · Proceedings of The Nutrition Society · doi:10.1079/pns19960012 · Cited by 10
“However, the observation that LPL does not become saturated until triacylglycerol concentrations reach approximately 5 mmoVl (Brunzell et al. 1973), and that in adipose tissue suppression of VLDL removal occurs before CM concentrations have reached a plateau (Potts et al. 1991), suggest the…”
BackgroundNovel PPARG mutation in multiple family members with chylomicronemia
Glodowski, M., Christen, S., Saxon, D. R., Hegele, R. A., & Eckel, R. H. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.03.006 · Cited by 8
Hwu, C., Lin, M., Liou, T., Hsiao, L., Liang, K.-W., Tsai, T.-T., & Ho, L. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31800577856 · Cited by 7
Treatment of hypertriglyceridemia
Capell, W. H., & Eckel, R. H. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0040-9 · Cited by 10
“This accumulation arises because lipolytic clearance of TGs from the circulation displays saturation kinetics [ 49 ].”
BackgroundAre Plasma Triglyceride Concentrations Explained by Saturation Kinetics?
Grundy, S. M., & Vega, G. L. (1982) · Elsevier eBooks · doi:10.1016/b978-0-12-092480-6.50025-5 · Cited by 7
Triglycerides and Cardiovascular Disease : A Scientific Statement From the
Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6
Fat Emulsion Catabolism in Vitro and in Vivo—Sex Related Differences
Jesmok, G. J., Woods, E. F., Ditzler, W. S., & Walsh, G. M. (1981) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607181005003200 · Cited by 6
Therapeutic targets in severe hypertriglyceridemia
Capell, W. H., Spiegelman, K. P., & Eckel, R. H. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.09.012 · Cited by 5
Aviram, M., Rosenblat, M., Potesman, M., Dankner, G., & Brook, J. G. (1986) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(86)90085-x · Cited by 5
Alves, J. F. R., Britto, R. P. D. A., Ferreira, H. S., Sawaya, A. L., & Florêncio, T. M. D. M. T. (2014) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2013.12.006 · Cited by 5
Metadata
- Authors
- Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Brunzell, John D.
- Venue
- Journal of Clinical Investigation
- Published
- 1973-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1578-1585
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC302428
- OpenAlex
- W2077829695
- Cited by
- 484
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 3 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 8 · 2012: 6
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- VLDL, triglyceride-rich lipoproteins, lipoprotein lipase, Michaelis-Menten kinetics, carbohydrate intake, dietary fat, heparin infusion, lipolysis
- MeSH terms
- Adult, Chylomicrons, Dietary Carbohydrates, Dietary Fats, Female, Heparin, Humans, Hydrolysis, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Male, Middle Aged, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.